Status:
COMPLETED
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Germ Cell Cancer
Eligibility:
MALE
15+ years
Brief Summary
The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects.
Detailed Description
Identification of late-effects through questionnaires and linkage to national registries. DNA samples will be gathered through buccal swabs or saliva kits and analysed with whole exome-sequencing.
Eligibility Criteria
Inclusion
- Danish citizen
- Diagnosed with germ cell cancer from 1984 to 2007
- Treated initially at a Danish hospital
- Treated with standard treatment regimens.
Exclusion
- Treated initially at a foreign hospital
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT02303015
Start Date
August 1 2014
End Date
June 1 2023
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Oncology, Rigshospitalet
Copenhagen, Denmark, 2100